The life science industry has created over 5,000 jobs in the canton of Zurich over the past ten years. That doesn’t just help the economy.
—
—
At Molecular Partners in Schlieren, protein molecules are being developed that will also be used to combat Sars-CoV-2.
—
They develop drugs against Covid-19 disease or use magnets to fish toxins out of the blood. These are just two of the business models of companies that have settled in the Bio-Technopark in Schlieren. In the mid-1980s, ETH began setting up laboratories where railway wagons and elevators were once manufactured. What started out small has now grown into a life science cluster. 55 companies with 1500 employees in the fields of pharmaceuticals, bio and medical technology cavort on the area. And are thus a symbol for a rapidly growing industry.
–
Related posts:
Maryland Confirms Very first West Nile Virus Scenario Of The Calendar year | DC | Washington, DC
Implementation of Wolbachia Ing Kota (Wingko) Semarang to Control Dengue Hemorrhagic Fever in Indone...
Despite Corona: Many films and series are made in Hamburg | NDR.de - Nachrichten - Hamburg
Almost 77,000 sick leaves in Vienna – 5 minutes
